×

Access Whitepaper

First Name
Last Name
Company
Thank you!
Error - something went wrong!
   

Clinical Trial Recruitment Practices: The Evolution of Ethical Considerations

Recruitment practices for clinical trials have evolved significantly over the last few decades. In addition to the advances in recruitment advertising through social media and other technologies, there are a number of practices that used to be considered acceptable, and even standard, which are no longer considered acceptable. At the same time, other practices, such as study sponsors providing direct staffing support for busy clinical sites, have become more popular.

Read this white paper to learn about the evolution of acceptable recruitment practices, and what IRB members typically look for when reviewing recruitment materials and practices.

Download this whitepaper to read more.

 

About the Author

Dr. Lindsay McNair, MD, MPH, MSB | Chief Medical Officer, WCG

Dr. Lindsay McNair has extensive experience in the pharmaceutical industry. Prior to joining WCG, she was a consultant to pharmaceutical and biotechnology companies, providing medical guidance on clinical development strategies and study designs for new drug studies, and medical oversight of all phases of clinical trials. Dr. McNair teaches graduate-level courses on the scientific design of clinical research studies. She has been actively involved in IRB work for 18 years, and has a Master’s of Science in Bioethics with a concentration in research ethics.

Follow on Twitter Follow on Linkedin Visit Website More Content by Dr. Lindsay McNair, MD, MPH, MSB | Chief Medical Officer, WCG
Previous Flipbook
Avoid Enrollment Pitfalls: Find Your Best-fit Clinical Trial Sites
Avoid Enrollment Pitfalls: Find Your Best-fit Clinical Trial Sites

Selecting the right site is the single most crucial decision you’ll make about your next clinical trial. An...

Next Video
Optimizing Global Safety Reporting in Clinical Trials
Optimizing Global Safety Reporting in Clinical Trials

Learn how a large, global pharmaceutical company saved millions of dollars by optimizing their safety repor...